Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2004-05-18
2010-06-01
Tate, Christopher R. (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07727560
ABSTRACT:
The present invention relates to a method of suppressing malignant conditions, including cancer with complications such like hepatitis and platelet disorder in bleeding, by administering a composition of an extract ofCanavalia ensiformis. Also, the invention is nontoxic to the individual and for improving functions of kidney as well as of liver, especially when involved in cancer.
REFERENCES:
patent: 4636463 (1987-01-01), Altman et al.
patent: 4985543 (1991-01-01), Sugita et al.
patent: 5830887 (1998-11-01), Kelly
patent: 6004558 (1999-12-01), Thurn et al.
patent: 6129919 (2000-10-01), Chen et al.
patent: 6562380 (2003-05-01), Kelly
patent: 6669956 (2003-12-01), He et al.
patent: 2002/0160060 (2002-10-01), Kim Chen et al.
patent: 2001089346 (2001-04-01), None
Broder, G. Presentation Highlights—Complications of Cancer. 3rd Annual Joint Cancer Conf. Florida Univ. Jan. 1999. 9 pages, Downloaded from Internet site www.moffitt.usf.edu.
Wecksler et al. Acta Cientifica Venezolana. 1968. vol. 9, No. 4, pp. 154-156, CAPLUS Abstract enclosed.
Swaffar et al. Anti-Cancer Drugs. 1995. vol. 6, No. 4, pp. 586-593, EMBASE Abstract enclosed.
Markman, M. Cleveland Clinic J. Med. 1994. vol. 64, No. 2, pp. 105-114.
Ellis et al. Am. J. Clin. Oncol. 1986. vol. 9, No. 6, pp. 533-536, MEDLINE Abstract enclosed.
Tartter et al. Am. J. Surgery. 1986. vol. 152, No. 5, pp. 479-482, MEDLINE Abstract enclosed.
Feld, R. Lung Cancer. 1994. vol. 10, Suppl. 1, pp. S307-S317, MEDLINE Abstract enclosed.
L.W. Lee, Study on Anticancer Activity by Orally Administered ConA; J. Chinese Oncol. Soc. II(3), 27-34. 1995. Taipei. Taiwan.
H. Louis, Production and Role of IL-10 in ConA Induced-Hepatitis; J. Hepatology, 1997. USA.
Y. Kaneko, Augmentation of Vα14NKT Cell-Mediated Cytotoxicity by IL-4 in an Autocrine Mechanism Resulting in Development of ConA Induced Hepatitis; J. of Experimental Medicine vol. 191. No. 1, Jan. 3, 2000; USA.
Egan, H.S., Supression of a Thymus Dependent Humoral Reponse in Mice by ConA In Vivo.; Cell Immunol; vol./issue 18:1. 1975. Chicago. USA.
International Immunology, vol. 11, No. 9. 1491-1500, Sep. 1999 Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanava.
Biochem J. Nov. 15, 2001: 360(Pt 1): 217-224. Copyright notice Canatoxin, a toxic protein from jack beans (Canavalia ensiformis), is a variant form of urease (EC 3.5.1.5.
LandOfFree
Treating cancer, liver, kidney, platelet and hemopoietic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating cancer, liver, kidney, platelet and hemopoietic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating cancer, liver, kidney, platelet and hemopoietic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4190191